BioMarin is in a shrinking state. Attempt to break into big pharma has failed. The company needs to scale down to survive. The business organization does not need structures present in big pharma in wait to grow. Many areas have to be trimmed down or eliminated. The examples can be Technical Development, Data Science. Process Sciences, Downstream Process Development, Analytical Development, Formulation, Business Development, and so on. The top of the company must be cleansed from dead wood and overweight. Inflated management titles should be scaled down with reduction of salaries and bonuses. The last should be suspended completely as long as the company is in decline. Investors are not happy despite of periodic news of future prospects. It is a time to act fast, this time from top down. Without victimizing productive people at the base who are crucial in bringing products daily thru unjustified layoffs.
We watch the GLP-1 current developments. We believe we will be less adversely affected than Novo. Our organization is more lean and efficient than Novo with all their internal deficiencies, redundant staff, lack of expertise of many employees and bad decision making.
Roche has destroyed Genentech. The change of culture involved sending in Roche managers.Two organisations were incompatible. Do not hire ex-Roche and ex-Genentech managers. They will bring specific Roche toxic style with them.
The CEO tolerates many poor performers at the top. Some of them are dismaying. No direction, no vision, no new products development, aimless activities of departments and redundancy.
Maria Z & Ricky S make this job unbearable. Many of my physicians have told me not to bring either of them
around. The company has a terrible culture. When I came onboard I worked with Andrew, the recruiter. He is like a cringe game show host with no talent or professionalism. This was the worst career decision I’ve made.
The company could not have reached its full potential for decades. This is an organizational problem and cannot be overcome under current management structure. Let them drift and watch.
Just an equipment maker. Do not expect any expertise. Worse, their new masters NN do not understand these processes neither. Management not having a clue pushes employees to produce AI generated generic reviews that they do not understand and cannot explain. Then pushes them out. Even Singh Singh cannot help them. Circus from a little town.
Drug price corrections would result in payroll reduction and this is a chance to remove workers from two large countries who steal technology and jobs from americans
